검색어 : 통합검색[Miles Alastair.]
총 68건 중 68건 출력
, 3/7 페이지
-
21
- Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to CA1 by differential modulation of feedforward inhibitory circuits
- Palacios-Filardo, Jon; Udakis, Matt; Brown, Giles A.; Tehan, Benjamin G.; Congreve, Miles S.; Nathan, Pradeep J.; Brown, Alastair J. H.; Mellor, Jack R.; Center for Synaptic Plasticity, School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk, Bristol, UK; Center for Synaptic Plasticity, School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk, Bristol, UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abingdon, Cambridge, UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abingdon, Cambridge, UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abingdon, Cambridge, UK; Department of Psychiatry, University of Cambridge, Cambridge, UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abingdon, Cambridge, UK; Center for Synaptic Plasticity, School of Physiology, Pharmacology and Neuroscience, University of Bristol, University Walk, Bristol, UK; (Nature communications, v.12, 2021, pp.5475)
-
22
- Acetylcholine prioritises direct synaptic inputs from entorhinal cortex to 1 CA1 by differential modulation of feedforward inhibitory circuits
- Palacios-Filardo Jon; Udakis Matt; Brown Giles A.; Tehan Benjamin G.; Congreve Miles S.; Nathan Pradeep J.; Brown Alastair J.H.; Mellor Jack R.; ; (, v., 2020, )
-
23
- Spatial profiling of central nervous system cellular markers in murine breast cancer to brain metastases
- Karen Hogg; Grant Calder; Alastair Droop; Ming Yang; Anna Simon; Mark J Hunt; Paul M Kaye; Miles Whittington; Sangeeta Chawla; William J Brackenbury; ; (, v., 2025, )
-
24
- What does the world think of ankyloglossia?
- Jin, Ruilin R.; Sutcliffe, Alastair; Vento, Maximo; Miles, Claudelle; Travadi, Javeed; Kishore, Kumar; Suzuki, Keiji; Todd, David; Wooderson, Susanne; Kamar, Azanna Ahmad; Ma, Li; Smyth, John; Oei, Ju Lee; School of Women's and Children's Health University of New South Wales Randwick NSW Australia; PPP Theme UCL and Great Ormond Street Institute of Child Health London UK; Division of Neonatology University and Polytechnic Hospital La Fe Valencia Spain; Clinical Midwifery Consultant for Lactation Services Royal Hospital for women Randwick NSW Australia; Department of Neonatology John Hunter Children's Hospital Newcastle NSW Australia; Cloudnine Hospitals Bangalore India; Department of Pediatrics Tokai University School of Medicine Isehara Kanagawa Japan; Department of Neonatology Canberra Hospital Garran ACT Australia; Department of Neonatology John Hunter Children's Hospital Newcastle NSW Australia; Department of Neonatology University of Malaya Medical Centre Kuala Lumpur Malaysia; Department of Paediatrics Shijiazhuang Children's Hospital Shijiazhuang Hebei Province China; School of Women's and Children's Health University of New South Wales Randwick NSW Australia; School o; (Acta pædiatrica = Acta Paediatrica, v.107, 2018, pp.1733-1738)
-
25
- The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients
- Lees, Jennifer S.; Rankin, Alastair J.; Gillis, Keith A.; Zhu, Luke Y.; Mangion, Kenneth; Rutherford, Elaine; Roditi, Giles H.; Witham, Miles D.; Chantler, Donna; Panarelli, Maurizio; Jardine, Alan G.; Mark, Patrick B.; ; (American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, v.21, 2021, pp.3356-3368)
-
26
- Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial
-
Thomas, Martin Geoffrey;
Bayliss, Carrie;
Bond, Simon;
Dowling, Francis;
Galea, James;
Jairath, Vipul;
Lamb, Christopher;
Probert, Christopher;
Timperley-Preece, Elizabeth;
Watson, Alastair;
Whitehead, Lynne;
Williams, John G;
Parkes, Miles;
Kaser, Arthur;
Raine, Tim;
Cambridge Clinical Trials Unit , Cambridge , UK;
Cambridge Clinical Trials Unit , Cambridge , UK;
Cambridge Clinical Trials Unit , Cambridge , UK;
Cambridge Clinical Trials Unit , Cambridge , UK;
University of Manchester , Manchester , UK;
Division of Gastroenterology, Department of Medicine , Western University , London , Ontario , Canada;
Institute of Cellular Medicine , Newcastle University , Newcastle upon Tyne , UK;
Institute of Translational Medicine , University of Liverpool , Liverpool , UK;
Coventry , UK;
Department of Gastroenterology , University of East Anglia , Norwich , UK;
Clinical Trials Pharmacy Department , Addenbrooke’s Hospital , Cambridge , UK;
Swansea University Medical School , Swansea , UK
-
27
- Zinc stable isotopes in urine as diagnostic for cancer of secretory organs
- Schilling, Kathrin; Moore, Rebekah E T; Sullivan, Kaj V; Capper, Miles S; Rehkä mper, Mark; Goddard, Kate; Ion, Charlotte; Coombes, R Charles; Vesty-Edwards, Lois; Lamb, Alastair D; Halliday, Alex N; Larner, Fiona; Lamont-Doherty Earth Observatory, Columbia University, Palisades, NY, USA; Department of Earth Science and Engineering, Imperial College London, London, UK; Department of Renewable Resources, University of Alberta, Alberta, Canada; Department of Earth Science and Engineering, Imperial College London, London, UK; Department of Earth Science and Engineering, Imperial College London, London, UK; Imperial College Healthcare NHS Trust, London, UK; Imperial College Healthcare NHS Trust, London, UK; Imperial College Healthcare NHS Trust, London, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Earth Institute, Columbia University, New York, NY, USA; Department of Earth Sciences, University of Oxford, South Parks Road, Oxford, UK; (Metallomics : integrated biometal science, v.13, 2021, pp.mfab020)
-
28
- Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M <sub>1</sub> receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study
- Bakker, Charlotte; Tasker, Tim; Liptrot, Jan; Hart, Ellen P.; Klaassen, Erica S.; Doll, Robert Jan; Brown, Giles A.; Brown, Alastair; Congreve, Miles; Weir, Malcolm; Marshall, Fiona H.; Cross, David M.; Groeneveld, Geert Jan; Nathan, Pradeep J.; Centre for Human Drug Research (CDHR), Zernikedreef 8, 2333 CL Leiden, The Netherlands; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG UK; Centre for Human Drug Research (CDHR), Zernikedreef 8, 2333 CL Leiden, The Netherlands; Centre for Human Drug Research (CDHR), Zernikedreef 8, 2333 CL Leiden, The Netherlands; Centre for Human Drug Research (CDHR), Zernikedreef 8, 2333 CL Leiden, The Netherlands; OMass Therapeutics Ltd, Oxford, UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG UK; Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge, CB21 6DG UK; Merck Sharp & Dohme Limited, London, UK; Cross Pharma Consulting Limited, Cambridge, UK; Centre for Human Drug Research (CDHR), Zernikedreef 8, 2333 CL Lei; (Alzheimer's research & therapy, v.13, 2021, pp.87)
-
29
- Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M<sub>1</sub>‐acetylcholine receptor agonist: A randomized cross‐over trial
- Bakker, Charlotte; Prins, Samantha; Liptrot, Jan; Hart, Ellen P.; Klaassen, Erica S.; Brown, Giles A.; Brown, Alastair; Congreve, Miles; Weir, Malcolm; Marshall, Fiona H.; Stevens, Jasper; Cross, David M.; Tasker, Tim; Nathan, Pradeep J.; Groeneveld, Geert Jan; Centre for Human Drug Research, Leiden, The Netherlands; Centre for Human Drug Research, Leiden, The Netherlands; Sosei Heptares, Cambridge, UK; Centre for Human Drug Research, Leiden, The Netherlands; Centre for Human Drug Research, Leiden, The Netherlands; Sosei Heptares, Cambridge, UK; Sosei Heptares, Cambridge, UK; Sosei Heptares, Cambridge, UK; Sosei Heptares, Cambridge, UK; Sosei Heptares, Cambridge, UK; Centre for Human Drug Research, Leiden, The Netherlands; Cross Pharma Consulting Ltd, Cambridge, UK; Sosei Hept; (British journal of clinical pharmacology, v.87, 2021, pp.4439-4449)
-
30
- A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M <sub>1</sub> receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease
- Nathan, Pradeep J.; Millais, S. Babli; Godwood, Alex; Dewit, Odile; Cross, David M.; Liptrot, Janet; Ruparelia, Bharat; Jones, Stephen Paul; Bakker, Geor; Maruff, Paul T.; Light, Gregory A.; Brown, Alastair J.H.; Weir, Malcolm Peter; Congreve, Miles; Tasker, Tim; Heptares Therapeutics Ltd Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; Cross Pharma Consulting Limited Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; tranScrip Partners LLP Wokingham UK; Heptares Therapeutics Ltd Cambridge UK; Cogstate Ltd New Haven Connecticut USA; Department of Psychiatry University of San Diego San Diego California USA; Heptares Therapeutics Ltd Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; Heptares Therapeutics Ltd Cambridge UK; (Alzheimer's & dementia. Translational research & clinical interventions, v.8, 2022, pp.e12273)
QUICK MENU
